• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向 NF-κB 和 HIF-1 通路治疗癌症:第一部分。

Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part I.

机构信息

"Polish Mother's Health Center" Research Institute, Lodz, Poland.

出版信息

Arch Immunol Ther Exp (Warsz). 2011 Aug;59(4):289-99. doi: 10.1007/s00005-011-0131-4. Epub 2011 May 28.

DOI:10.1007/s00005-011-0131-4
PMID:21625848
Abstract

The process of chronic inflammation is a common link which connects different kinds of environmental pollutants and infections with tumorigenesis. Transcription factor NF-κB is a common final target for many inflammatory and cell proliferation pathways, independent of the source of stimuli (e.g., cytokines, growth factors, environmental carcinogens, radiation, hypoxia, bacteria, and viruses). Over-activation of NF-κB has been confirmed in many tumors, resulting in worse prognosis for patient survival. Therefore, inhibition of cellular pathways for NF-κB activation is nowadays considered as a promising anti-cancer therapy and is extensively studied in clinical trials, or even has been adopted as an approved therapy in some kinds of cancer.

摘要

慢性炎症的发生过程是一个共同的环节,它将不同类型的环境污染物和感染与肿瘤发生联系起来。转录因子 NF-κB 是许多炎症和细胞增殖途径的共同最终靶点,而与刺激源(例如细胞因子、生长因子、环境致癌物、辐射、缺氧、细菌和病毒)无关。在许多肿瘤中已经证实 NF-κB 的过度激活,导致患者生存预后更差。因此,抑制 NF-κB 激活的细胞途径被认为是一种有前途的抗癌治疗方法,目前正在临床试验中广泛研究,甚至在某些类型的癌症中已被采用为一种批准的治疗方法。

相似文献

1
Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part I.靶向 NF-κB 和 HIF-1 通路治疗癌症:第一部分。
Arch Immunol Ther Exp (Warsz). 2011 Aug;59(4):289-99. doi: 10.1007/s00005-011-0131-4. Epub 2011 May 28.
2
Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part II.靶向 NF-κB 和 HIF-1 通路治疗癌症:第二部分。
Arch Immunol Ther Exp (Warsz). 2011 Aug;59(4):301-7. doi: 10.1007/s00005-011-0132-3. Epub 2011 May 28.
3
Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.用6-氨基-4-喹唑啉阻断白细胞介素-6信号通路可协同诱导硼替佐米对人U266细胞的抑制作用。
Anticancer Drugs. 2008 Sep;19(8):777-82. doi: 10.1097/CAD.0b013e32830c236a.
4
NF-κB and the link between inflammation and cancer.NF-κB 与炎症和癌症之间的联系。
Immunol Rev. 2012 Mar;246(1):379-400. doi: 10.1111/j.1600-065X.2012.01099.x.
5
Intracellular inhibitory effects of Velcade correlate with morphoproteomic expression of phosphorylated-nuclear factor-kappaB and p53 in breast cancer cell lines.万珂(硼替佐米)在乳腺癌细胞系中的细胞内抑制作用与磷酸化核因子-κB和p53的形态蛋白质组学表达相关。
Ann Clin Lab Sci. 2005 Winter;35(1):15-24.
6
Can NF-kappaB be a target for novel and efficient anti-cancer agents?核因子-κB能否成为新型高效抗癌药物的靶点?
Biochem Pharmacol. 2006 Oct 30;72(9):1054-68. doi: 10.1016/j.bcp.2006.07.023. Epub 2006 Sep 14.
7
Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer.硼替佐米蛋白酶体抑制剂对胃癌的抗肿瘤活性。
Int J Oncol. 2011 Dec;39(6):1529-36. doi: 10.3892/ijo.2011.1141. Epub 2011 Jul 22.
8
The cross-talk between NF-kappaB and HIF-1: further evidence for a significant liaison.核因子-κB与缺氧诱导因子-1之间的相互作用:存在重要联系的进一步证据
Biochem J. 2008 Jun 15;412(3):e17-9. doi: 10.1042/BJ20080920.
9
Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer.黄酮类化合物通过靶向炎症通路预防和治疗癌症。
Planta Med. 2010 Aug;76(11):1044-63. doi: 10.1055/s-0030-1250111. Epub 2010 Jul 15.
10
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.与肿瘤相关脂肪酸合酶依赖性乳腺癌细胞增殖和存活相关的新型信号分子:外源性膳食脂肪酸、p53-p21WAF1/CIP1、ERK1/2 MAPK、p27KIP1、BRCA1和NF-κB的作用
Int J Oncol. 2004 Mar;24(3):591-608.

引用本文的文献

1
Crosstalk between hypoxic cellular micro-environment and the immune system: a potential therapeutic target for infectious diseases.缺氧细胞微环境与免疫系统的串扰:传染病潜在的治疗靶点。
Front Immunol. 2023 Jul 31;14:1224102. doi: 10.3389/fimmu.2023.1224102. eCollection 2023.
2
Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.卵巢癌中的癌症干细胞——肿瘤成功的根源和新型治疗的挑战性靶点。
Int J Mol Sci. 2022 Feb 24;23(5):2496. doi: 10.3390/ijms23052496.
3
Personalized Immunotherapy in Colorectal Cancers: Where Do We Stand?
结直肠癌的个性化免疫治疗:我们目前的进展如何?
Front Oncol. 2021 Nov 23;11:769305. doi: 10.3389/fonc.2021.769305. eCollection 2021.
4
A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells .一种表达IL-24的条件性复制腺病毒与替莫唑胺协同作用,增强黑色素瘤细胞的凋亡。
Oncol Lett. 2017 Jun;13(6):4185-4189. doi: 10.3892/ol.2017.6007. Epub 2017 Apr 7.
5
Quercetin induces bladder cancer cells apoptosis by activation of AMPK signaling pathway.槲皮素通过激活AMPK信号通路诱导膀胱癌细胞凋亡。
Am J Cancer Res. 2016 Jan 15;6(2):498-508. eCollection 2016.
6
Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions.肿瘤对血管破坏剂的耐药性:机制、成像及解决方案。
Oncotarget. 2016 Mar 29;7(13):15444-59. doi: 10.18632/oncotarget.6999.
7
S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.S-亚硝基谷胱甘肽介导的信号转导和转录激活因子3(STAT3)调控在头颈部鳞状细胞癌放疗和顺铂治疗疗效中的作用
Redox Biol. 2015 Dec;6:41-50. doi: 10.1016/j.redox.2015.07.001. Epub 2015 Jul 2.
8
Low-dose triptolide in combination with idarubicin induces apoptosis in AML leukemic stem-like KG1a cell line by modulation of the intrinsic and extrinsic factors.低剂量雷公藤红素联合伊达比星通过调节内在和外在因素诱导 AML 白血病干样 KG1a 细胞系凋亡。
Cell Death Dis. 2013 Dec 5;4(12):e948. doi: 10.1038/cddis.2013.467.
9
Modulators of HIF1α and NFkB in Cancer Treatment: Is it a Rational Approach for Controlling Malignant Progression?癌症治疗中 HIF1α 和 NFkB 的调节剂:控制恶性进展的合理方法?
Front Pharmacol. 2013 Feb 12;4:13. doi: 10.3389/fphar.2013.00013. eCollection 2013.
10
A novel mithramycin analogue with high antitumor activity and less toxicity generated by combinatorial biosynthesis.组合生物合成产生的具有高抗肿瘤活性和低毒性的新型丝裂霉素类似物。
J Med Chem. 2012 Jun 28;55(12):5813-25. doi: 10.1021/jm300234t. Epub 2012 Jun 7.